ANBENITAMAB REPODATECAN
UNII 3U4SXA9ADW

Substance Identification & Data

This profile provides standardized clinical and technical data for Anbenitamab Repodatecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3U4SXA9ADW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2923420-38-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3U4SXA9ADW

CAS Registry Number

2923420-38-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANBENITAMAB REPODATECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190145

National Cancer Institute reference terminology for clinical and research data.

INN ID

13457

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anbenitamab Repodatecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.